A short-term assessment of routine chemistry parameters using sigma metrics

INTRODUCTION

Clinical laboratories serve as a fundamental component of any healthcare system, as healthcare providers depend significantly on the results they provide to inform patient care decisions. Research indicates that laboratory results influence 70% to 75% of medical diagnoses, highlighting the critical role that the quality of laboratory services plays in determining the overall effectiveness of healthcare delivery. To ensure that laboratory results are beneficial within a clinical context, it is essential for them to be both accurate and timely. Moreover, reliable laboratory operations are crucial for facilitating optimal patient outcomes. Inaccurate laboratory results can result in a range of serious repercussions, including unnecessary treatments, complications, inappropriate care, delays in accurate diagnosis, and redundant diagnostic testing.^[1]

The laboratory operates as a sophisticated system, encompassing numerous steps and skilled personnel. The entire sequence of operations involved in testing is known as the Path of Workflow, which starts with the patient and culminates in the reporting and interpretation of results. While errors can occur in any clinical laboratory, our ability to manage a growing volume of samples with a focused team ensures that we minimise mistakes throughout the process. Each stage of the total testing process (TTP) is crucial, and any error in sample analysis can impact laboratory results. To uphold the highest standards of quality, we are committed to implementing effective methods for error detection within the TTP framework.^[2]

Quality is defined as the extent to which a product or service meets the requirements of end users. It is evaluated based on several key factors, including accuracy (the proximity of results to the true value), precision, sensitivity, and specificity. In clinical laboratories, sigma metrics are utilised to assess quality in a systematic and quantitative manner.^[3]

The sigma metric serves as a composite measure encompassing total allowable error (specific to each method), bias = analytical systematic error (derived from external quality assessment systems), and imprecision (as indicated by the coefficient of variation percentage from internal quality control). This analysis provides a standardised framework for comparing the quality of test performance.

Higher sigma metric values signify a reduction in analytical errors and an overall decrease in questionable test outcomes. For instance, a six-sigma assay indicates that 99.99966% of results are error-free, which corresponds to approximately 3.4 defects per million opportunities. Furthermore, the application of sigma metrics facilitates the establishment of appropriate quality control protocols to ensure consistent excellence in testing.^[4–6]

Today, laboratories face the challenge of managing increased workloads and a wider range of testing parameters with limited staff. They must deliver consistent, high-quality results within defined turnaround times in a cost-effective manner.^[7]

The performance of laboratory operations can be effectively assessed through the implementation of Six Sigma methodologies.^[8] Utilising Sigma metric analysis offers an objective evaluation of analytical methods and instrumentation while also supplying crucial design information necessary for successful operational execution.

Six Sigma is a quality management strategy designed to enhance process quality by focusing on the identification and elimination of defects. Quality is assessed on a sigma scale, with three- sigma representing the minimum acceptable performance and six- sigma designated as the benchmark for world-class quality.^[9] An increase in the sigma value indicates improved consistency and reliability in testing, which can lead to a reduction in operational costs. In this context, we aim to evaluate the process performance of several commonly tested parameters, including Albumin, Alkaline Phosphate (ALP), alanine aminotransferase (ALT), Amylase, aspartate aminotransferase (AST), Calcium, Chloride, Cholesterol, Creatinine, Glucose, High-density lipoprotein (HDL), Iron, Potassium, Sodium, Total Bilirubin, Total Protein, Triglycerides, Urea, and Uric Acid, using the sigma scale.^[10] This assessment will facilitate the identification of effective strategies for enhancing the performance of target analytes and will contribute to cost reduction associated with the establishment of calibration curves and the analysis of densitometry data.

Clinical labs are a key part of modern healthcare systems since many clinical decisions are dependent on the findings of laboratory tests. Because a significant percentage of clinical decisions are dependent on laboratory test findings, clinical labs are an essential component of contemporary healthcare systems. According to several medical survey reports, between 70% and 75% of medical diagnoses are based at least partially on laboratory data, highlighting the critical role that laboratory services play in patient care and clinical results. As a result, timely, accurate, and reliable laboratory findings are crucial requirements for efficient healthcare delivery. Suboptimal laboratory performance may lead to diagnostic mistakes, improper therapeutic approaches, delayed treatment, wasteful repeat testing, higher healthcare spending, and potential injury to patients.^[1]

Laboratory testing is intrinsically complicated and entails a number of connected procedures carried out by knowledgeable staff utilising cutting-edge analytical tools. Pre-analytical, analytical, and post-analytical stages are included in this sequence, which is also known as the TTP. It starts with test selection and specimen collection and ends with result reporting and clinical interpretation. Errors can occur at any point in the TTP, but they can have an influence on the entire process and eventually lower the standard of patient care. Therefore, continual monitoring and rigorous control of all stages of the TTP are crucial for detecting sources of error and adopting remedial steps to increase overall laboratory performance.

Quality in clinical laboratory practice is defined as the extent to which testing services meet the requirements and expectations of doctors and patients. Several quality indicators, including accuracy, precision, sensitivity, specificity, and repeatability, are frequently used to assess it. Although useful, traditional quality control methods frequently evaluate these factors separately and might not give a whole picture of analytical performance. In order to evaluate and compare test results across various analytes and devices, laboratories are increasingly in need of integrated, objective, and quantitative tools.^[2]

Sigma metrics have come to be an excellent way to quantify quality that meets this demand by giving a single measure of analytical performance. The sigma metric contains three important components: total permitted error, method bias (usually acquired from external quality assessment or proficiency testing programs), and imprecision (represented as the coefficient of variation received from internal quality control data). Sigma metrics allow for standardised comparison of assay performance and support evidence-based quality management choices by condensing numerous factors into a single numerical value.^[3]

Higher sigma values suggest higher analytical quality and a decreased probability of obtaining erroneous results. A six-sigma process, for instance, amounts to around 3.4 errors per million chances, reflecting a standard of world-class performance. Sigma metrics are essential for developing and refining quality control methods in addition to assessing analytical quality. Assays with higher sigma values may require less severe quality control procedures, whereas lower-performing assays require more intensive monitoring, hence increasing effective resource utilisation without compromising result dependability.^[4–6]

Clinical laboratories have encountered more difficulties in recent years as a result of growing test volumes, expanded test menus, scarce human resources, and increased demands for quick turnaround times, all while maintaining cost-effective operations.^[7]

In these circumstances, the Six Sigma technique has become well-known as an organised approach to quality management that aims to reduce defects, improve process consistency, and boost operational effectiveness.^[8]

Within laboratory medicine, Six Sigma concepts provide a rigorous framework for reviewing analytical procedures, enhancing workflow processes, and supporting ongoing quality improvement programs.^[9]

The current study uses sigma metrics to evaluate the analytical performance of a variety of commonly requested biochemical parameters, including albumin, alkaline phosphatase, alanine aminotransferase, amylase, aspartate aminotransferase, calcium, chloride, cholesterol, creatinine, glucose, high-density lipoprotein, iron, potassium, sodium, total bilirubin, total protein, triglycerides, urea, and uric acid. The evaluation's conclusions should help identify analytes that need focused quality improvement, optimise quality control procedures and promote economic laboratory management while guaranteeing the provision of accurate and clinically significant test results.^[10]

The biochemical parameters selected for this study were chosen based on their high testing frequency and clinical importance in routine laboratory practice. These analytes are commonly used for the evaluation and monitoring of major physiological systems, including liver function (Albumin, ALP, ALT, Aspartate Aminotransferase, Total Bilirubin, and Total Protein), renal function (Urea, Creatinine, and Uric Acid), electrolyte balance (Sodium, Potassium, Chloride, and Calcium), lipid metabolism (Cholesterol, Triglycerides, and HDL ), and glycaemic status (Glucose). Due to their widespread use in screening, diagnosis, disease monitoring, and therapeutic decision-making, ensuring the analytical reliability of these parameters is essential. Their routine nature and high clinical impact make them well-suited for sigma metric evaluation to identify performance gaps and optimise quality control practices.

MATERIAL AND METHODS

This study is a retrospective analysis conducted to evaluate data extracted from Yes Labs in Hyderabad, Telangana, India, between June 2022 and September 2022. The information gathered encompasses the Internal Quality Control (IQC) coefficient of variation percent (CV%) and External Quality Assessment Scheme (EQAS) bias% for 19 biochemical parameters: Albumin, ALP, ALT, Amylase, AST, Calcium, Chloride, Cholesterol, Creatinine, Glucose, HDL, Iron, Potassium, Sodium, Total Bilirubin, Total Protein, Triglycerides, Urea, and Uric Acid.^[11–13] The purpose of this study is to assess the performance of these parameters as measured by a fully automated biochemistry analyser, with evaluations conducted on the Sigma Scale. We conduct daily IQC at two levels. Using the IQC data, we compute the mean and the standard deviation (SD), followed by the CV%. Our facility participates in the EQAS program offered by the Christian Medical College (CMC) in Vellore, Tamil Nadu, India. The EQAS program requires us to submit our monthly results within a week of the submission deadline. Bias is defined as the discrepancy between the average and the actual values.^[13–16] We estimate bias% using EQAS software and the relevant equation.

The error percentage was utilised to determine the Sigma (σ) value. To calculate the Total acceptable error (TEA) values for clinical biochemistry parameters, the J. Cameron (RICOS) Guidelines were followed.

Specifically, sigma metrics were calculated using the formula Sigma = (TEA − bias) / CV, and QGI was calculated as QGI = Bias / (1.5 × CV). TEA values were obtained from established guidelines.

Microsoft Office Excel 2021 and Origin 2025 Pro were employed. Data capture and statistical analyses were conducted utilising Microsoft Excel on the Windows® 10 operating system (Microsoft Corporation, Redmond, Washington, United States). The analyses executed include the calculation of bias, CV, critical error TEA, sigma metrics, and the Quality Grade Index (QGI), as previously detailed.^[17]

RESULTS

The range of sigma ratings employed in the selection of quality control (QC) criteria is delineated in Table 1. In the present study, IQC and EQAS data for 6 months (June 2022–November 2022) were collected and compiled in Excel sheets to calculate mean, SD, CV%, bias [Table 2], and Sigma Metrics for 19 different parameters. While evaluating IQC, it can be observed that only a few parameters, that are ALT, ALP, and Urea, had CV% >5, and the rest of all parameters showed CV% <5 [Table 3]^[18]

The bias% month-wise and average for all parameters, the CV% for control levels, and the sigma value month-wise and cumulative for all parameters bias% are given in Tables 2-4.

The analytical performance of 19 routinely assessed biochemical parameters was examined over a six-month duration (June– November) utilising bias percentage ((bias%)), CV%, and sigma metrics obtained from IQC and EQAS data [Tables 2-4]. All three quality indicators showed significant month-to-month variations and inter-analyte variability.

An analyte-specific bias study showed both positive and negative systematic deviations, with average bias percentage values ranging from 8.68% for ALT to -12.35 percent for cholesterol. A number of analytes showed comparatively low average bias values, suggesting that they agreed well with the designated target values. Iron (0.25%), total protein (−0.89%), triglycerides (−1.06%), HDL (−1.26%), glucose (1.08%), albumin (1.36%), sodium (1.24%), and chloride (2.05%) were among them. On the other hand, cholesterol (−12.35%), AST (−9.55%), total bilirubin (−7.03%), ALP (−5.13%), and creatinine (−2.94%) showed greater negative bias, indicating a systematic underestimate in comparison to peer group or goal levels. ALT (8.68%), urea (3.13%), calcium (2.81%), and uric acid (2.50%) all showed significant positive bias.

A number of analytes showed significant month-to-month variability, including AST, ALT, Amylase, Total Bilirubin, and Urea, which reflected variations in analytical accuracy over the research period.

The total CV% values obtained by imprecision analysis ranged from 1.11% (Sodium) to 7.73% (ALP). Low CV% values were found for sodium (1.11%), total protein (1.37%), cholesterol (1.83%), glucose (1.92%), calcium (1.96%), iron (2.25%), and chloride (1.55%), demonstrating consistent analytical accuracy. ALP (7.73%), ALT (7.55%), Urea (5.75%), HDL (4.28%), Uric Acid (4.32%), Triglycerides (3.21%), and AST (4.23%) all showed moderate to high imprecision. These higher CV% findings imply increased random error and highlight the necessity for more strict quality control monitoring for these analytes.

The Sigma metric study revealed significant diversity in overall analytical performance. Cumulative sigma values varied from -0.50 (Sodium) to 16.52 (Total Protein). Analytes were divided into three groups based on conventional sigma performance criteria: high, moderate, and low-performing. Excellent analytical performance (≥6 sigma) was reported for total protein (16.52), iron (14.33), triglycerides (11.73), cholesterol (11.62), total bilirubin (11.56), AST (6.39), and Amylase (7.39). These analytes consistently produced high sigma values over several months, demonstrating great analytical dependability. Creatinine (4.51), HDL (3.21), Glucose (3.07), and Uric Acid (2.87) demonstrated moderate performance (3-6 sigma). Although usually satisfactory, some metrics displayed performance oscillations that need ongoing monitoring.

Poor performance (<3 sigma) was seen for Albumin (0.91), ALP (2.26), ALT (2.55), Urea (2.53), Potassium (2.36), Calcium (-0.11), Chloride (-0.31), and Sodium (-0.50). Negative sigma values obtained for many electrolytes and proteins during specific months show that the combined bias and imprecision surpassed the permitted error limits.^[18]

DISCUSSION

In the ongoing effort to uphold high laboratory quality standards, Six Sigma is regarded as a vital tool. The Lean Six Sigma methodology specifically aims to minimise wasteful activities throughout the sample processing workflow.^[19] When the sigma metric reaches 6 or higher, it indicates a process efficiency of only 3.4. Defects Per Million Opportunities (DPMO) is a benchmark recognised as “world-class quality”. “While attaining a sigma metric of 6 or above poses significant challenges, it is achievable through diligent efforts to reduce errors across all phases of sample processing, including pre-analytical, analytical, and post-analytical stages. In the current study, data from IQC and EQC over six months (June 2022 to November 2022) were examined to calculate the mean, SD, CV% [Figures 1-2], bias, and sigma metrics for 19 analytes. The SD and CV% are used to assess the degree of deviation and variation, respectively, of IQC test results from the mean. Generally, the CV% is the preferred method for presentation.^[20] A CV of less than 5% indicates that the method used to determine an analyte's concentration demonstrates very good performance, and precision.^[21]

Close

Figure 1:

Demographical representation of the coefficient of variance (CV%). Monthly (June 2022-November 2022) ALP: Alkaline phosphate, ALT: Alanine aminotransferase, AST: Aspartate aminotransferase, HDL: High-density lipoprotein , BUN: Blood urea nitrogen, GGT: Gamma glutamyl transferase, GPT: Glutamate pyruvate transaminase, GOT: Glutamate Oxaloacetate transaminase.

Export to PPT

Close

Figure 2:

Pie chat-based graphical representation for cumulative monthly CV% representation. ALP: Alkaline phosphate, ALT: Alanine aminotransferase, AST: Aspartate aminotransferase, HDL: High-density lipoprotein.

Export to PPT

In clinical laboratories, assessing the calibre of laboratory testing is a crucial area of research. To comprehensively and methodically guide quality management in clinical laboratories, Six Sigma quality standards consider bias(systematic error) and CV (random error). This allows for the analysis of potential mistake causes, the identification of remedies, improved testing quality assurance, and QC schedule optimisation. It is still unclear, nevertheless, what the ideal TEA, bias, CV, and other indications are for calculating 6σ, especially when the sources of bias% and CV differ throughout laboratories. ^[22,23] A hypothesis is developed and investigated, and the root reasons are discovered. Ultimately, corrective action is performed, and the process is continually monitored. Quality assurance systems are built around the “find a problem, repair a problem” mindset, which ignores the underlying process that caused the problem. Systematic techniques must be examined to achieve major gains in laboratory performance. The Six Sigma concept is widely acknowledged as world-class quality for laboratory measurements, and it may be expressed as () = (TEA% -bias%) / CV%, where TEA% is the total permitted inaccuracy percentage. Outside of healthcare, 3 Sigma is regarded as the minimum tolerable process performance.^[24]

When performance goes less than 3 Sigma, the method is deemed unbalanced and unsatisfactory. Healthcare &Clinical labs seem to be functioning in a 2 to 3 Sigma environment, in contrast to other businesses. This is owing to the widespread usage of 2s (two standard deviations or two SD) control limits, which can result in erroneous rejection rates of up to 20%, depending on the number of controls conducted. Misapplication of 2s limits in laboratory testing usually leads to incorrectly repeated controls, needless troubleshooting, or, worse, workarounds that artificially broaden control limits to the point that laboratories can no longer identify significant analytical mistakes.^[25] Six Sigma metrics, along with a reasonable QC design for each analyte, can enhance quality by lowering waste.

The Six Sigma approach is the best solution for solving analytical or administrative problems in laboratory medicine and reducing mistakes to a bare minimum. To trim down the rate of mistakes, in order to minimise the need for human interaction, we should always employ high-quality technology. While applying cutting-edge technology to every medical speciality is feasible, laboratory medicine offers the opportunity to do so.

Six Sigma is a quality scientist's microscope that reveals the truth rather than hiding flaws. The mistakes of interest are generally analytical in nature, and they are merely the tip of the iceberg. When we can see the entire iceberg and manage it, we will be able to achieve Six Sigma and even greater excellence in clinical laboratories.^[26]

The most essential information in this essay is that when sigma is applied to parameters with restricted biological variation, the likelihood of low sigma values increases. Furthermore, it is critical not to impose any severe criteria in the laboratory, as this might result in excessive waste of time, resources, people, and erroneous rejections. Lastly, it is proposed that for parameters with less than three sigma values, root cause analysis be performed, as well as a combined evaluation of IQC and EQAS.^[27]

Maintaining high analytical quality standards is critical in clinical laboratory practice, and Six Sigma technique has emerged as an effective tool for objectively monitoring and improving laboratory performance.^[19] Lean Six Sigma, in particular, aims to reduce mistakes and waste across the testing workflow, including the pre-analytical, analytical, and post-analytical stages. A sigma score of 6 or above equates to a defect rate of just 3.4 per million chances DPMO, which is usually regarded as the standard for world-class quality. Although obtaining such performance remains difficult in typical laboratory settings, ongoing monitoring and focused quality improvement programs can significantly minimize analytical mistakes. In the current study, data from IQC and EQAS were collected over six months (June-November 2022) to calculate bias, SD, CV% [Figure 1-2], and sigma metrics for 19 routinely tested biochemical analytes. CV% was employed as the major indication of analytical accuracy because it offers a standardised measure of variability that is not affected by analyte concentration.^[20] In general, a CV% of less than 5% is regarded suggestive of high analytical accuracy, and numerous analytes in this investigation met this threshold, demonstrating adequate technique consistency.^[21]

Six Sigma metrics integrate total permitted error TEA, random error (imprecision), and systematic error bias to give a thorough evaluation of analytical quality. With the use of this integrated approach, laboratories may optimize quality control techniques, pinpoint the underlying reasons of analytical failure, and shift from the conventional “detect and correct” mentality to systematic process improvement.^[22,23]

However, the selection of TEA and laboratory-specific sources of bias and imprecision, which might differ depending on the context, affect how sigma results are interpreted. ^[24]

Even though there was some discernible bias in this investigation, analytes such as total protein, iron, cholesterol, triglycerides, and total bilirubin showed good sigma performance. This good performance may be explained by comparatively larger TEA limits and low CV%, which point to reliable analytical techniques and efficient quality control procedures. Current QC practices seem adequate for these high-performing analytes, and streamlined QC guidelines might be taken into consideration to maximise resource use without sacrificing analytical accuracy.

For creatinine, glucose, HDL, and uric acid, moderate sigma performance was seen, indicating adequate analytical quality but greater vulnerability to performance degradation if bias or imprecision rises.

In many instances, sigma values were constrained by modest CV% or varying bias, highlighting the necessity of ongoing observation and recurring technique evaluation to avoid analytical drift. Albumin, ALP, ALT, urea, and electrolytes, including calcium, sodium, potassium, and chloride, all showed poor sigma performance. Higher imprecision and variable bias were the main causes of lower sigma values for enzyme tests like ALP and ALT, suggesting the need for better calibration verification, reagent lot validation, and more frequent IQC. These results emphasise the value of analyte-specific quality control design as opposed to depending only on standard QC guidelines. Electrolytes showed a clear pattern of performance. Extremely tight TEA limits resulted in low or even negative sigma values despite relatively low bias and CV%. This highlights a crucial drawback of sigma metrics: even small analytical variations can have a big influence on sigma values when used for analytes with strict biological variation and performance requirements. As a result, too strict acceptance standards might result in a high number of erroneous rejections, more effort, and wasteful use of lab resources.

Many clinical laboratories have historically operated within a 2–3 sigma performance range, in part because 2s control procedures are often used.^[25] High false rejection rates, needless repeat testing, extensive troubleshooting, and, in some situations, improper control limit broadening that hides actual analytical faults are all consequences of such procedures. By striking a balance between error detection and operational efficiency, the use of sigma metrics in conjunction with analyte-specific QC design provides a more logical and effective approach to quality assurance.^[26]

Several analytes in this investigation showed month-to-month fluctuation, which highlights how dynamic normal laboratory performance is. These variations may be caused by variables such as reagent lot changes, calibration adjustments, instrument maintenance, and environmental factors. Early detection of analytical instability and prompt remedial action are supported by ongoing assessment utilising sigma metrics. This study shows that a strong framework for assessing analytical performance, spotting flaws, and directing focused quality improvement measures is provided by the combined evaluation of bias, CV%, and sigma metrics. Root cause analysis and integrated interpretation of IQC and EQAS data are highly advised for analytes with sigma values less than three. Laboratories may maintain cost-effective operations while increasing patient safety, reducing waste, and improving analytical dependability via the prudent implementation of Six Sigma concepts.^[27]

CONCLUSION

The significance of a single test result frequently determines the course of subsequent care, as laboratory data are essential for patient diagnosis, monitoring, and prognosis. Therefore, laboratories should strive to reduce mistakes that may have an impact on patient outcomes. When used for quality management, the sigma metrics tool may be a useful tool for tracking analytical performance against international benchmarks. Establishing standardised protocols is crucial for determining sigma metrics, since it involves selecting suitable TEA criteria and calculating bias methods.

Sigma metrics play a crucial role in enhancing clinical laboratories by providing a structured approach to identify and address deviations in lab results from established standards. This methodology not only highlights areas of poor assay performance but also evaluates the efficiency of current laboratory processes. By integrating Sigma metrics with lean Six Sigma principles, laboratories can streamline operations, eliminating unnecessary and time-consuming steps. This leads to reduced TAT and the more efficient delivery of high-quality reports, ultimately improving patient management. Furthermore, sigma metrics can be instrumental in developing effective strategies for the optimal use of IQC and EQC within large clinical laboratories, fostering continuous improvement and ensuring the highest standards of care.

In laboratory medicine, quality is a continuous process, and if the TEA% of a parameter is on the lower side, there are better possibilities of obtaining a good sigma value. To provide quality work, it is suggested that root cause analysis be performed on those parameters with fewer than three sigma values. It also finds that the sigma matrix provides a combined evaluation of IQC and EQAS. To provide high-end or world-class quality, quality personnel should not only create CV%, bias%, and TEA% of any parameter but also monitor the sigma matrix. Sigma metrics is a key tool for quality and patient safety, as well as an additional challenge for laboratory management.

This study shows how the Six Sigma technique may be used practically as a thorough tool for assessing analytical performance in standard clinical biochemistry labs. Sigma metrics, which include bias. Imprecision CV% and total permitted error provide a transparent and impartial evaluation of test quality for 19 frequently used biochemical parameters.

Strong analytical techniques and efficient quality control procedures were demonstrated by the exceptional sigma performance of a number of analytes, including total protein, iron, cholesterol, triglycerides, and total bilirubin. On the other hand, metrics including creatinine, glucose, HDL, and uric acid show intermediate sigma performance, which emphasises the necessity of ongoing quality monitoring to stop performance decline. The results also highlight the need for careful interpretation of sigma measurements and customised quality control schemes since analytes with restricted biological variation, especially electrolytes, are more vulnerable to low sigma values even with acceptable bias and accuracy. While sigma-based techniques allow for optimised QC planning, targeted corrective measures, and effective resource utilisation, routine reliance on consistent quality control procedures may result in inefficiencies.

All things considered, a strong foundation for raising analytical dependability, lowering mistakes, and boosting patient safety in clinical laboratories is provided by the methodical use of sigma metrics, which is backed by ongoing assessment of IQC and EQAS data.

Cost-effective healthcare delivery and long-term laboratory performance improvement can be supported by the implementation of analyte-specific Six Sigma-guided quality management techniques.